Trial Of Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab (Bevacizumab) For Treatment Of Relapsed/Refractory Glioblastoma Multiforme And Anaplastic Astrocytoma.
This study is currently recruiting participants.
Verified December 2012 by Weill Medical College of Cornell University
Weill Medical College of Cornell University
Information provided by (Responsible Party):
John A. Boockvar, Weill Medical College of Cornell University
First received: December 22, 2010
Last updated: December 18, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||October 2015|
|Estimated Primary Completion Date:||October 2014 (Final data collection date for primary outcome measure)|